AMGEN INC Quarterly Other Assets, Current in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current assets classified as other.
Summary
Amgen Inc quarterly Other Assets, Current history and growth rate from Q1 2010 to Q3 2024.
  • Amgen Inc Other Assets, Current for the quarter ending September 30, 2024 was $3.08B, a 19.9% increase year-over-year.
Other Assets, Current, Quarterly (USD)
Other Assets, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $3.08B +$511M +19.9% Sep 30, 2024 10-Q 2024-10-31
Q2 2024 $2.98B +$652M +28.1% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $2.82B +$426M +17.8% Mar 31, 2024 10-Q 2024-05-03
Q4 2023 $2.6B +$214M +8.96% Dec 31, 2023 10-Q 2024-10-31
Q3 2023 $2.57B +$64M +2.56% Sep 30, 2023 10-Q 2023-10-31
Q2 2023 $2.32B +$66M +2.92% Jun 30, 2023 10-Q 2023-08-04
Q1 2023 $2.4B -$93M -3.74% Mar 31, 2023 10-Q 2023-04-28
Q4 2022 $2.39B +$21M +0.89% Dec 31, 2022 10-K 2024-02-14
Q3 2022 $2.5B -$41M -1.61% Sep 30, 2022 10-Q 2022-11-04
Q2 2022 $2.26B -$165M -6.81% Jun 30, 2022 10-Q 2022-08-05
Q1 2022 $2.49B +$195M +8.5% Mar 31, 2022 10-Q 2022-04-28
Q4 2021 $2.37B +$288M +13.9% Dec 31, 2021 10-K 2023-02-09
Q3 2021 $2.54B +$277M +12.2% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 $2.42B +$155M +6.83% Jun 30, 2021 10-Q 2021-08-04
Q1 2021 $2.29B +$183M +8.67% Mar 31, 2021 10-Q 2021-04-28
Q4 2020 $2.08B +$191M +10.1% Dec 31, 2020 10-K 2022-02-16
Q3 2020 $2.27B -$1.08B -32.4% Sep 30, 2020 10-Q 2020-10-29
Q2 2020 $2.27B +$257M +12.8% Jun 30, 2020 10-Q 2020-07-29
Q1 2020 $2.11B +$47M +2.28% Mar 31, 2020 10-Q 2020-05-01
Q4 2019 $1.89B +$94M +5.24% Dec 31, 2019 10-K 2021-02-09
Q3 2019 $3.35B +$1.41B +72.5% Sep 30, 2019 10-Q 2019-10-30
Q2 2019 $2.01B +$3M +0.15% Jun 30, 2019 10-Q 2019-07-31
Q1 2019 $2.06B +$131M +6.78% Mar 31, 2019 10-Q 2019-05-01
Q4 2018 $1.79B +$67M +3.88% Dec 31, 2018 10-K 2020-02-12
Q3 2018 $1.94B -$129M -6.23% Sep 30, 2018 10-Q 2018-10-31
Q2 2018 $2.01B -$686M -25.5% Jun 30, 2018 10-Q 2018-07-27
Q1 2018 $1.93B -$7M -0.36% Mar 31, 2018 10-Q 2018-04-25
Q4 2017 $1.73B -$288M -14.3% Dec 31, 2017 10-K 2019-02-13
Q3 2017 $2.07B +$73M +3.66% Sep 30, 2017 10-Q 2017-10-26
Q2 2017 $2.69B +$530M +24.5% Jun 30, 2017 10-Q 2017-07-26
Q1 2017 $1.94B +$123M +6.77% Mar 31, 2017 10-Q 2017-04-27
Q4 2016 $2.02B +$312M +18.3% Dec 31, 2016 10-K 2018-02-13
Q3 2016 $2B -$295M -12.9% Sep 30, 2016 10-Q 2016-10-28
Q2 2016 $2.16B -$233M -9.72% Jun 30, 2016 10-Q 2016-07-29
Q1 2016 $1.82B -$896M -33% Mar 31, 2016 10-Q 2016-05-02
Q4 2015 $1.7B -$789M -31.7% Dec 31, 2015 10-K 2017-02-14
Q3 2015 $2.29B -$441M -16.1% Sep 30, 2015 10-Q 2015-11-02
Q2 2015 $2.4B -$92M -3.7% Jun 30, 2015 10-Q 2015-08-05
Q1 2015 $2.71B -$308M -10.2% Mar 31, 2015 10-Q 2015-04-27
Q4 2014 $2.49B +$242M +10.8% Dec 31, 2014 8-K 2016-10-31
Q3 2014 $2.73B +$684M +33.4% Sep 30, 2014 10-Q 2014-10-29
Q2 2014 $2.49B +$281M +12.7% Jun 30, 2014 10-Q 2014-08-05
Q1 2014 $3.02B +$861M +39.9% Mar 31, 2014 10-Q 2014-04-30
Q4 2013 $2.25B +$364M +19.3% Dec 31, 2013 10-K 2015-02-19
Q3 2013 $2.05B +$283M +16% Sep 30, 2013 10-Q 2013-10-29
Q2 2013 $2.21B +$421M +23.6% Jun 30, 2013 10-Q 2013-08-06
Q1 2013 $2.16B +$165M +8.28% Mar 31, 2013 10-Q 2013-05-03
Q4 2012 $1.89B +$314M +20% Dec 31, 2012 10-K 2014-02-24
Q3 2012 $1.77B +$94M +5.62% Sep 30, 2012 10-Q 2012-11-06
Q2 2012 $1.79B +$421M +30.8% Jun 30, 2012 10-Q 2012-08-08
Q1 2012 $1.99B +$278M +16.2% Mar 31, 2012 10-Q 2012-05-08
Q4 2011 $1.57B +$222M +16.4% Dec 31, 2011 10-K 2013-02-27
Q3 2011 $1.67B +$278M +19.9% Sep 30, 2011 10-Q 2011-11-04
Q2 2011 $1.37B +$45M +3.41% Jun 30, 2011 10-Q 2011-08-08
Q1 2011 $1.72B +$497M +40.8% Mar 31, 2011 10-Q 2011-05-10
Q4 2010 $1.35B Dec 31, 2010 10-K 2012-02-29
Q3 2010 $1.39B Sep 30, 2010 10-Q 2010-11-08
Q2 2010 $1.32B Jun 30, 2010 10-Q 2010-08-09
Q1 2010 $1.22B Mar 31, 2010 10-Q 2010-05-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.